These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8629885)

  • 21. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG vaccination with antitubercular therapy.
    Amdekar YK
    Indian Pediatr; 1998 Oct; 35(10):1046-8. PubMed ID: 10216738
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid resistance among tuberculosis patients by birth cohort in Germany.
    Forssbohm M; Loddenkemper R; Rieder HL
    Int J Tuberc Lung Dis; 2003 Oct; 7(10):973-9. PubMed ID: 14552568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
    Nolan CM
    Am J Respir Crit Care Med; 2003 Aug; 168(4):412-3. PubMed ID: 12912731
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
    Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [30 years of isoniazid (INH) treatment].
    Terracina S; Lewit T
    Harefuah; 1985 Feb; 108(4):213-6. PubMed ID: 4007674
    [No Abstract]   [Full Text] [Related]  

  • 30. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
    Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More on the question of optimal chemotherapy in the presence of isoniazid resistance.
    Long R; Scalcini M
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):890-4. PubMed ID: 10985663
    [No Abstract]   [Full Text] [Related]  

  • 33. Isoniazid prophylaxis in end-stage renal disease.
    Bal AM
    Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141
    [No Abstract]   [Full Text] [Related]  

  • 34. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presumptive TB prophylaxis rejected.
    Torres G
    GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid.
    Tuberculosis (Edinb); 2008 Mar; 88(2):112-6. PubMed ID: 18486045
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid resistant TB and non-compliance.
    van Altena R; van Soolingen D; van der Werf TS
    Thorax; 2004 Dec; 59(12):1098; author reply 1098-9. PubMed ID: 15563712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.